Market Overview:
The global glaucoma treatment drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of glaucoma, rising awareness about glaucoma and its treatment, and technological advancements in the field of ophthalmology. The oral typeglaucomegment dominates the globalmarket, owing tothe high adoption rateof thesedrugsamong patientsand their easeof use.
Product Definition:
The drugs used to treat glaucoma are called ophthalmic medications. They work by reducing the amount of fluid in the eye or by improving the drainage of fluid from the eye. Glaucoma medications can be either topical (applied directly to the eye) or systemic (taken by mouth).
Oral Type Glaucoma Treatment Drugs:
Oral type glaucoma is a rare disease that affects the nerve connecting the eye and the brain, causing increased pressure in the eye. The normal pressure of a human eye is 7 to 8 mmHg; if this level increases, it becomes painful for an individual to look at things far away or even read newspaper. High intraocular pressure (IOP) can lead to severe damage including blindness; thus, it has gained much attention in medical field over recent years.
Injection Type Glaucoma Treatment Drugs:
Injection type glaucoma (IUG) is a form of glaucoma, which occurs when the nerve that supplies the eye with salt and water is compressed or damaged. The most common cause of IUG is infection in the cornea - chlamydia trachomatis. Other causes include injury to the nerve that controls eye flow (queen bee venom), autoimmune disease such as lupus, diabetes mellitus, etc.
Application Insights:
The hospital type was the dominant application segment and accounted for a revenue share of around 60.0% in 2017. The rising prevalence of glaucoma coupled with increasing awareness about early diagnosis is driving the demand for these drugs in hospital settings. In addition, a rise in the number of government initiatives to control or reduce eye diseases such as glaucoma is expected to boost market growth over the forecast period. For instance, according to WHO, there are currently more than 70 million people suffering from glaucoma worldwide and it is anticipated that by 2050 this number will reach 132 million globally which would indicate an increase of 61%. Similarly, data published by IAPB Vision Atlas states that out of 17 million blind people due to Glaucoma; nearly 9 million are expected to be sightless by 2050 if action isn¢â‚¬â„¢t taken now!.
Regional Analysis:
North America held the largest share of global market in 2017. The region is expected to maintain its dominance during the forecast period due to presence of a large number of patients with open eye condition and increasing awareness about treatment options. In addition, availability of reimbursement facilities for open-angle glaucoma treatments also boosts regional growth.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to rising disposable income, improving healthcare infrastructure and growing population with risk factors such as diabetes that increase susceptibility for developing glaucoma conditions. Moreover, government initiatives are undertaken in countries like India & China for controlling blindness caused by this disease which will boost regional growth further. For instance, Chinese Government has provided funds worth USD X million towards research on trabeculectomy surgery developed by Drs Charles River Laboratories (CRL).
Growth Factors:
- Increasing prevalence of glaucoma: Glaucoma is a leading cause of blindness and it is estimated that around 3 million people in the U.S. are affected by the disease. The number of people with glaucoma is expected to increase due to the aging population. This will create demand for glaucoma treatment drugs.
- Technological advances: There has been significant progress in the field of ophthalmology in recent years, with new technologies being developed for diagnosis and treatment of glaucoma. This will help to drive growth for the glaucoma treatment drugs market.
- Growing awareness about glaucoma: There is growing awareness about Glaucoma among patients and healthcare professionals alike, which is helping to drive demand for these drugs .This trend is likely to continue in future, resulting in further growth for this market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Glaucoma Treatment Drugs Market Research Report
By Type
Oral Type Glaucoma Treatment Drugs, Injection Type Glaucoma Treatment Drugs
By Application
Hospital, Clinic, Home Care
By Companies
Aerie Pharmaceuticals, Akorn Inc., Alcon, Allergan plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co. Inc, Pfizer Inc, Santen Pharmaceutical Co. Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Glaucoma Treatment Drugs Market Report Segments:
The global Glaucoma Treatment Drugs market is segmented on the basis of:
Types
Oral Type Glaucoma Treatment Drugs, Injection Type Glaucoma Treatment Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aerie Pharmaceuticals
- Akorn Inc.
- Alcon
- Allergan plc
- Bausch & Lomb Incorporated
- Inotek Pharmaceuticals
- Merck & Co. Inc
- Pfizer Inc
- Santen Pharmaceutical Co. Ltd
Highlights of The Glaucoma Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Type Glaucoma Treatment Drugs
- Injection Type Glaucoma Treatment Drugs
- By Application:
- Hospital
- Clinic
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glaucoma Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glaucoma treatment drugs are medications that are used to lower the pressure in the eye caused by glaucoma. These medications can help to reduce the risk of blindness from glaucoma.
Some of the major companies in the glaucoma treatment drugs market are Aerie Pharmaceuticals, Akorn Inc., Alcon, Allergan plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co. Inc, Pfizer Inc, Santen Pharmaceutical Co. Ltd.
The glaucoma treatment drugs market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glaucoma Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glaucoma Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glaucoma Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glaucoma Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glaucoma Treatment Drugs Market Size & Forecast, 2020-2028
4.5.1 Glaucoma Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Glaucoma Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Type Glaucoma Treatment Drugs
5.2.2 Injection Type Glaucoma Treatment Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glaucoma Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glaucoma Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Type Glaucoma Treatment Drugs
9.6.2 Injection Type Glaucoma Treatment Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Type Glaucoma Treatment Drugs
10.6.2 Injection Type Glaucoma Treatment Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Type Glaucoma Treatment Drugs
11.6.2 Injection Type Glaucoma Treatment Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Type Glaucoma Treatment Drugs
12.6.2 Injection Type Glaucoma Treatment Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Type Glaucoma Treatment Drugs
13.6.2 Injection Type Glaucoma Treatment Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glaucoma Treatment Drugs Market: Competitive Dashboard
14.2 Global Glaucoma Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aerie Pharmaceuticals
14.3.2 Akorn Inc.
14.3.3 Alcon
14.3.4 Allergan plc
14.3.5 Bausch & Lomb Incorporated
14.3.6 Inotek Pharmaceuticals
14.3.7 Merck & Co. Inc
14.3.8 Pfizer Inc
14.3.9 Santen Pharmaceutical Co. Ltd
